India Chemotherapy at Home Service Market to be grow by 10.21% through 2030
The expansion in tier-2 and tier-3
cities is expected to drive the growth of India chemotherapy at home service
market in the forecast period, 2026-2030.
According to TechSci Research report, “India Chemotherapy
at Home Service Market - By Region, Competition, Forecast and
Opportunities, 2030F”, The India Chemotherapy at Home Service Market was
valued at USD 51.23 Million in 2024 and is expected to reach USD 91.28 Million
by 2030, growing with a CAGR of 10.21% in the forecast period. This
can be ascribed to the less risk involved when you are treated at home rather
than a hospital. Hospitals and clinics can be sources of infections, especially
for patients with weakened immune systems. By receiving chemotherapy at home,
patients are exposed to fewer people and have less risk of contracting an
infection. In a home setting, patients can receive more personalized care, with
medical professionals who are dedicated to their treatment. This can help to
identify and manage any complications that may arise more quickly.
Patients may feel more comfortable and relaxed in
their own home, which can help to reduce stress and anxiety, and may even
contribute to better treatment outcomes. Patients who receive chemotherapy at
home may be more likely to adhere to their treatment regimen since they do not
have to travel to a hospital or clinic, which can be time-consuming, anxious,
and stressful. With remote monitoring technology, medical professionals can
monitor patients continuously, which can help to identify any issues that may
arise and intervene quickly if necessary.
Major need of the chemotherapy at home service market
is to grow focus on quality and safety. Chemotherapy at home service providers
must comply with regulatory standards set by the government and healthcare
authorities to ensure that patients receive safe and effective care. Providers
can obtain accreditation and certification from independent organizations to
demonstrate their commitment to quality and safety. Providers must ensure that
their staff are trained and educated in best practices for administering
chemotherapy at home, including infection control, medication safety, and
emergency response. Providers must have processes in place to ensure that
chemotherapy drugs are stored and administered safely, and that patients
receive the correct dosages at the right times. Also, providers should seek
feedback from patients to identify areas for improvement and to ensure that
patients are satisfied with the care they receive.
Challenge which is being faced by India chemotherapy
at home service market is resistance from healthcare providers. Many healthcare
providers may not be familiar with the concept of chemotherapy at home and may
be hesitant to adopt this new model of care. Healthcare providers may be
concerned about the potential liability associated with providing chemotherapy
at home and may be hesitant to take on this risk. Providers may have concerns
about reimbursement for chemotherapy at home services and may be hesitant to
invest resources in developing these services without a clear path to
reimbursement.
Browse over XX Market Data Figures
spread through XX Pages and an in-depth
TOC on "India Chemotherapy at Home
Service Market”
India chemotherapy at home service market can be
segmented into by product, treatment stage, cancer type, distribution channel,
and region.
Based on cancer type, Breast cancer was the dominant
segment in the India chemotherapy at home service market. It is one of the most
commonly diagnosed cancers among women in India and often requires prolonged
and cyclical chemotherapy treatment. Many breast cancer patients are diagnosed
at stages where outpatient or home-based chemotherapy is clinically feasible,
making it suitable for transition to a home-care model. Patients undergoing
treatment for breast cancer often prefer receiving chemotherapy at home due to
the frequency of sessions and the physical and emotional fatigue associated
with hospital visits. Home-based care provides a comfortable and familiar environment,
allowing patients to stay close to family while minimizing the risk of
hospital-acquired infections. This is especially important for individuals with
compromised immunity during treatment cycles.
Healthcare providers also find breast cancer care more
manageable in home settings compared to more complex or unstable cancer types.
The protocols for breast cancer chemotherapy are relatively standardized, and
the risks during infusion are often lower, making it easier for trained home
healthcare professionals to administer treatment safely under remote oncologist
supervision. The widespread awareness around breast cancer, combined with
increased willingness among patients to explore personalized care options,
supports the strong demand for chemotherapy at home for this specific cancer
type in India..
Based on the distribution channel, Home Health
Agencies dominated the India chemotherapy at home service market due to
their structured approach, clinical expertise, and ability to deliver
end-to-end oncology care. These agencies offer a comprehensive service model,
including drug procurement, administration, monitoring, and emergency
protocols, all managed by trained medical professionals. Their ability to
provide oncology-trained nurses ensures safe and accurate chemotherapy
administration, which is critical in home settings. These agencies operate with
standardized protocols that align with clinical guidelines, giving patients and
oncologists confidence in the safety and reliability of home-based
chemotherapy. They often collaborate with hospitals and oncologists, creating a
seamless transition for patients from hospital-based treatment to home care.
This coordination helps maintain continuity of care, which is essential in
cancer treatment.
Home Health Agencies also invest in training
technology integration, and logistical support, such as cold chain management
for chemotherapy drugs. Their scale and professionalism allow them to serve
urban populations efficiently, where demand for home care is high. Patients
prefer these agencies for their ability to deliver personalized care while
maintaining medical rigor, making them the preferred and dominant providers in
India’s home chemotherapy market.
Major companies operating in India
chemotherapy at home service market are:
- Health Care at Home India Pvt Ltd.
- Purple Ribbon Healthcare Services Pvt Ltd.
- HCG Oncology Healthcare Pvt Ltd.
- Zoctr Health Pvt Ltd.
- Health Vista Pvt Ltd (Portea Medical)
- Medibank Private Ltd.
- Ubiqare Health
- Vitalis Health and Home Care
- TCP Homecare
- LloydsPharmacy Clinical Homecare
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The India chemotherapy-at-home service market has
experienced significant growth, driven by a combination of rising cancer
incidence and patient preference for convenience and personalized care.
Enhanced by professional home health agencies, this market has expanded beyond
major cities through stronger logistics, trained oncology nursing staff, and
widespread adoption of remote monitoring technologies. Partnerships between
hospitals and home-care providers facilitated smooth transitions of treatment
settings. Gradual insurance recognition added momentum, while increasing
patient awareness and comfort with telehealth boosted acceptance. Collectively,
these factors have fueled rapid market expansion, positioning home-based
chemotherapy as a viable and preferred option for many patients” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“India Chemotherapy
at Home Service Market, By Product (Chemotherapy
Drugs and Chemotherapy Infusion Pumps), By Treatment Stage (Early-Stage Cancer,
Advanced-Stage Cancer, Metastatic Cancer, and Recurrent Cancer), By
Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer,
and Others), By Distribution Channel (Home Health Agencies, Pharmacy-based
Services, Direct-to-Patient Services, and Others), By Region, Competition,
Forecast and Opportunities, 2020-2030F”, has evaluated the future
growth potential of India chemotherapy at home service market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India chemotherapy at home service market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com